Chrna7 (cholinergic receptor nicotinic alpha 7 subunit) - Rat Genome Database

Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Community Projects (beta) QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: Chrna7 (cholinergic receptor nicotinic alpha 7 subunit) Rattus norvegicus
Analyze
Symbol: Chrna7
Name: cholinergic receptor nicotinic alpha 7 subunit
RGD ID: 2348
Description: Enables several functions, including acetylcholine binding activity; acetylcholine-gated monoatomic cation-selective channel activity; and enzyme binding activity. Involved in several processes, including neuronal action potential; regulation of ERK1 and ERK2 cascade; and synaptic signaling. Acts upstream of or within calcium ion transport and regulation of membrane potential. Located in several cellular components, including dendrite; growth cone; and plasma membrane raft. Part of acetylcholine-gated channel complex. Is active in several cellular components, including glycinergic synapse; spine apparatus membrane; and synaptic membrane. Used to study cognitive disorder. Biomarker of rheumatoid arthritis. Human ortholog(s) of this gene implicated in chronic obstructive pulmonary disease; esophagus squamous cell carcinoma; respiratory system cancer (multiple); and schizophrenia. Orthologous to human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion) and CHRNA7 (cholinergic receptor nicotinic alpha 7 subunit); PARTICIPATES IN acetylcholine signaling pathway via nicotinic acetylcholine receptor; calcium/calcium-mediated signaling pathway; INTERACTS WITH (+)-Nornicotine; (S)-nicotine; 17alpha-ethynylestradiol.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: BTX; bungarotoxin alpha; C holinergic receptor nicotinic alpha polypeptide 7 (neuronal nicotinic acetycholine receptor alpha 7) (bungarotoxin alpha); C holinergic receptor, nicotinic, alpha polypeptide 7 (neuronal nicotinic acetycholine receptor alpha 7) (bungarotoxin alpha); cholinergic receptor, nicotinic, alpha 7; cholinergic receptor, nicotinic, alpha 7 (neuronal); cholinergic receptor, nicotinic, alpha polypeptide 7; nAChRa7; NARAD; neuronal acetylcholine receptor subunit alpha-7; neuronal nicotinic acetycholine receptor alpha 7; nicotinic receptor alpha 7 subunit
RGD Orthologs
Human
Mouse
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.21116,711,559 - 116,837,269 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1116,714,711 - 116,837,240 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1124,676,761 - 124,793,917 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01131,859,276 - 131,976,435 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01124,684,982 - 124,802,138 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01123,897,341 - 124,039,263 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1123,899,657 - 124,039,196 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01125,029,451 - 125,158,153 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41117,587,580 - 117,716,267 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11117,665,347 - 117,794,621 (-)NCBI
Celera1108,976,664 - 109,097,764 (-)NCBICelera
Cytogenetic Map1q22NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-beta-thujone  (ISO)
(+)-Nornicotine  (EXP)
(-)-cotinine  (ISO)
(-)-lobeline  (ISO)
(R)-adrenaline  (ISO)
(S)-nicotine  (EXP,ISO)
1,1-dimethyl-4-phenylpiperazinium iodide  (ISO)
1,2-dichloroethane  (ISO)
13-desmethylspirolide C  (ISO)
17alpha-ethynylestradiol  (EXP)
17beta-estradiol  (EXP)
2,3,7,8-tetrachlorodibenzodioxine  (EXP)
3,4-methylenedioxymethamphetamine  (ISO)
4,4'-sulfonyldiphenol  (EXP)
4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one  (ISO)
5-hydroxyindole  (EXP)
6-propyl-2-thiouracil  (EXP)
acetamiprid  (ISO)
acetylcholine  (EXP,ISO)
aflatoxin B1  (EXP,ISO)
all-trans-retinoic acid  (ISO)
alpha-pinene  (EXP)
ammonium chloride  (EXP)
Anabaseine  (EXP)
Anatoxin a  (EXP)
atracurium  (ISO)
benzo[a]pyrene  (ISO)
bis(2-ethylhexyl) phthalate  (ISO)
bisphenol A  (EXP,ISO)
bisphenol F  (EXP)
butanal  (ISO)
calcium atom  (EXP,ISO)
calcium(0)  (EXP,ISO)
cannabidiol  (ISO)
carbachol  (EXP,ISO)
carbon nanotube  (ISO)
chlorpyrifos  (EXP,ISO)
choline  (EXP,ISO)
cisatracurium  (ISO)
cisplatin  (ISO)
Citreoviridin  (ISO)
clothianidin  (ISO)
Cuprizon  (EXP)
cytisine  (EXP,ISO)
Desformylflustrabromine  (ISO)
dextran sulfate  (ISO)
Diacetoxyscirpenol  (ISO)
diazinon  (EXP)
dieldrin  (EXP)
dihydro-beta-erythroidine  (EXP,ISO)
dinophysistoxin 1  (ISO)
dioxygen  (ISO)
doxorubicin  (ISO)
epibatidine  (EXP,ISO)
epoxiconazole  (ISO)
ethanol  (EXP,ISO)
galanthamine  (ISO)
galanthamine Trifluoroacetic acid  (ISO)
gentamycin  (EXP)
GW 4064  (ISO)
herbicide  (ISO)
imidacloprid  (ISO)
ivermectin  (EXP)
lead diacetate  (EXP)
Licochalcone B  (ISO)
linoleic acid  (EXP)
lovastatin  (EXP,ISO)
LY294002  (ISO)
manganese(II) chloride  (ISO)
Mecamylamine  (EXP,ISO)
melittin  (EXP)
methyllycaconitine  (EXP,ISO)
Mivacurium  (ISO)
N-butyl-N-(4-hydroxybutyl)nitrosamine  (EXP)
N-nitrosodiethylamine  (EXP)
nickel atom  (EXP)
nicotine  (EXP,ISO)
nicotinic acetylcholine receptor agonist  (EXP)
okadaic acid  (ISO)
ozone  (ISO)
pancuronium  (ISO)
paracetamol  (ISO)
paraquat  (EXP)
parathion-methyl  (EXP)
PCB138  (EXP)
potassium dichromate  (ISO)
propanal  (ISO)
resveratrol  (ISO)
rocuronium  (ISO)
sodium arsenite  (ISO)
sodium fluoride  (EXP,ISO)
spinosad  (ISO)
sterigmatocystin  (EXP)
suramin  (ISO)
testosterone  (EXP)
tetrachloroethene  (EXP,ISO)
tetrodotoxin  (EXP)
titanium dioxide  (ISO)
toluene  (EXP,ISO)
topiramate  (EXP)
trichloroethene  (EXP)
tubocurarine  (ISO)
urethane  (ISO)
varenicline  (EXP)
vecuronium bromide  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
acetylcholine receptor signaling pathway  (IDA)
associative learning  (IEA,ISO)
B cell activation  (IEA,ISO)
behavioral response to ethanol  (IEA,ISO)
behavioral response to nicotine  (IEA,ISO)
calcium ion transport  (IMP,ISO)
cognition  (ISO)
dendrite arborization  (IEA,ISO)
dendritic spine organization  (IEA,ISO)
dopamine biosynthetic process  (IEP)
endocytosis  (IEA,ISO)
establishment of localization in cell  (IEA,ISO)
excitatory postsynaptic potential  (IEA)
flagellated sperm motility  (IEA,ISO)
generation of ovulation cycle rhythm  (IEA,ISO)
intracellular calcium ion homeostasis  (ISO)
learning or memory  (IMP,ISO)
memory  (IDA,IEA,ISO)
modulation of chemical synaptic transmission  (ISO)
modulation of excitatory postsynaptic potential  (ISO)
monoatomic ion transmembrane transport  (IDA,IEA,ISO)
monoatomic ion transport  (ISO)
negative regulation of amyloid-beta formation  (ISO)
negative regulation of ERK1 and ERK2 cascade  (IMP)
negative regulation of inflammatory response  (IEA,ISO)
negative regulation of interleukin-1 beta production  (IEA,ISO)
negative regulation of interleukin-6 production  (IEA,ISO)
negative regulation of protein phosphorylation  (IEA,ISO)
negative regulation of tumor necrosis factor production  (IEA,ISO)
neuronal action potential  (IMP)
ovulation cycle  (ISO)
positive regulation of amyloid-beta formation  (IEA,ISO)
positive regulation of angiogenesis  (ISO)
positive regulation of cell population proliferation  (ISO)
positive regulation of ERK1 and ERK2 cascade  (IDA,IEA,IMP,ISO)
positive regulation of excitatory postsynaptic potential  (IEA,ISO)
positive regulation of gene expression  (IDA)
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure  (IEA,ISO)
positive regulation of long-term synaptic potentiation  (IEA,ISO)
positive regulation of MAPK cascade  (ISO)
positive regulation of peptidyl-serine phosphorylation  (IEA,ISO)
positive regulation of protein metabolic process  (ISO)
positive regulation of protein phosphorylation  (ISO)
presynaptic modulation of chemical synaptic transmission  (EXP,IDA)
regulation of amyloid fibril formation  (IEA,ISO)
regulation of amyloid precursor protein catabolic process  (ISO)
regulation of inflammatory response  (ISO)
regulation of membrane potential  (IDA,IMP,ISO)
regulation of norepinephrine secretion  (IEA,ISO)
regulation of response to drug  (IDA)
regulation of synapse structural plasticity  (IEA,ISO)
regulation of synaptic transmission, dopaminergic  (IEA,ISO)
response to acetylcholine  (IDA,ISO)
response to amyloid-beta  (IEA,ISO)
response to carbamate  (IEP)
response to cold  (IEA,ISO)
response to ethanol  (ISO)
response to food  (IEA,ISO)
response to hypoxia  (ISO)
response to nicotine  (IDA,IGI,ISO)
sensory processing  (IDA,IEA,ISO)
signal transduction  (ISO)
synapse organization  (ISO)
synaptic transmission, cholinergic  (IBA,IEA,IMP,ISO)
T cell activation  (IEA,ISO)

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View

Mammalian Phenotype
References

References - curated
# Reference Title Reference Citation
1. Mammalian nicotinic acetylcholine receptors: from structure to function. Albuquerque EX, etal., Physiol Rev. 2009 Jan;89(1):73-120. doi: 10.1152/physrev.00015.2008.
2. Up-regulation of the human-specific CHRFAM7A gene in inflammatory bowel disease. Baird A, etal., BBA Clin. 2016 Jan 8;5:66-71. doi: 10.1016/j.bbacli.2015.12.003. eCollection 2016 Jun.
3. Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia. Barak S, etal., Neuropsychopharmacology. 2009 Jun;34(7):1753-63. doi: 10.1038/npp.2008.232. Epub 2009 Jan 21.
4. Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. Bitner RS, etal., J Neurosci. 2007 Sep 26;27(39):10578-87.
5. Targeting alpha7-nicotinic receptor for the treatment of pleural mesothelioma. Catassi A, etal., Eur J Cancer. 2008 Oct;44(15):2296-311. doi: 10.1016/j.ejca.2008.06.045. Epub 2008 Aug 20.
6. Involvement of the alpha 7 subunit of the nicotinic receptor in morphogenic and trophic effects of acetylcholine on embryonic rat spinal motoneurons in culture. Catone C and Ternaux JP, J Neurosci Res 2003 Apr 1;72(1):46-53.
7. Nicotinic cholinergic receptors in esophagus: Early alteration during carcinogenesis and prognostic value. Chianello Nicolau M, etal., World J Gastroenterol. 2016 Aug 21;22(31):7146-56. doi: 10.3748/wjg.v22.i31.7146.
8. The a7 nicotinic acetylcholine receptor function in hippocampal neurons is regulated by the lipid composition of the plasma membrane. Colón-Sáez JO and Yakel JL, J Physiol. 2011 Jul 1;589(Pt 13):3163-74. doi: 10.1113/jphysiol.2011.209494. Epub 2011 May 3.
9. Antisense knockdown of the rat alpha7 nicotinic acetylcholine receptor produces spatial memory impairment. Curzon P, etal., Neurosci Lett. 2006 Dec 13;410(1):15-9. doi: 10.1016/j.neulet.2006.09.061. Epub 2006 Oct 20.
10. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. Dineley KT, etal., J Neurosci. 2001 Jun 15;21(12):4125-33.
11. Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers. Drisdel RC and Green WN, J Neurosci. 2000 Jan 1;20(1):133-9.
12. Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. Fabian-Fine R, etal., J Neurosci. 2001 Oct 15;21(20):7993-8003.
13. Wnt-7a induces presynaptic colocalization of alpha 7-nicotinic acetylcholine receptors and adenomatous polyposis coli in hippocampal neurons. Farias GG, etal., J Neurosci. 2007 May 16;27(20):5313-25.
14. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Freedman R, etal., Proc Natl Acad Sci U S A 1997 Jan 21;94(2):587-92.
15. Ca2+ permeability of nicotinic acetylcholine receptors from rat dorsal root ganglion neurones. Fucile S, etal., J Physiol. 2005 May 15;565(Pt 1):219-28. Epub 2005 Mar 10.
16. Subsynaptic localization of nicotinic acetylcholine receptor subunits: a comparative study in the mouse and rat striatum. Garção P, etal., Neurosci Lett. 2014 Apr 30;566:106-10. doi: 10.1016/j.neulet.2014.02.018. Epub 2014 Mar 4.
17. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
18. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
19. PMCA2 via PSD-95 controls calcium signaling by alpha7-containing nicotinic acetylcholine receptors on aspiny interneurons. Gomez-Varela D, etal., J Neurosci. 2012 May 16;32(20):6894-905. doi: 10.1523/JNEUROSCI.5972-11.2012.
20. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. Khiroug SS, etal., J Physiol 2002 Apr 15;540(Pt 2):425-34.
21. Carbofuran induces apoptosis of rat cortical neurons and down-regulates surface alpha7 subunit of acetylcholine receptors. Kim SJ, etal., Mol Cells. 2004 Apr 30;17(2):242-7.
22. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. Klink R, etal., J Neurosci. 2001 Mar 1;21(5):1452-63.
23. The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat. Kristensen SE, etal., Neurosci Lett. 2007 May 17;418(2):154-8. doi: 10.1016/j.neulet.2007.03.016. Epub 2007 Mar 12.
24. Alpha7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. Levy RB and Aoki C, J Neurosci. 2002 Jun 15;22(12):5001-15.
25. Expression and localization analyses of the cholinergic anti-inflammatory pathway and α7nAchR in different tissues of rats with rheumatoid arthritis. Li Z, etal., Acta Histochem. 2019 Aug;121(6):742-749. doi: 10.1016/j.acthis.2019.07.001. Epub 2019 Jul 3.
26. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. Liu Q, etal., J Neurosci. 2009 Jan 28;29(4):918-29. doi: 10.1523/JNEUROSCI.3952-08.2009.
27. Postsynaptic alpha 4 beta 2 and alpha 7 type nicotinic acetylcholine receptors contribute to the local and endogenous acetylcholine-mediated synaptic transmissions in nigral dopaminergic neurons. Matsubayashi H, etal., Brain Res. 2004 Apr 16;1005(1-2):1-8.
28. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
29. Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors. Mishra NC, etal., J Immunol. 2010 Jul 1;185(1):588-96. doi: 10.4049/jimmunol.0902227. Epub 2010 May 26.
30. Modulation of neuronal nicotinic acetylcholine receptors by halothane in rat cortical neurons. Mori T, etal., Mol Pharmacol. 2001 Apr;59(4):732-43.
31. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
32. Axon targeting of the alpha 7 nicotinic receptor in developing hippocampal neurons by Gprin1 regulates growth. Nordman JC, etal., J Neurochem. 2014 May;129(4):649-62. doi: 10.1111/jnc.12641. Epub 2014 Jan 10.
33. Nicotinic acetylcholine receptor alpha 7 regulates cAMP signal within lipid rafts. Oshikawa J, etal., Am J Physiol Cell Physiol. 2003 Sep;285(3):C567-74. Epub 2003 May 14.
34. Protective effect of alpha7 nAChR: behavioural and morphological features on neuropathy. Pacini A, etal., Pain. 2010 Sep;150(3):542-549. doi: 10.1016/j.pain.2010.06.014. Epub 2010 Jul 8.
35. Inhibition of nonneuronal alpha7-nicotinic receptor for lung cancer treatment. Paleari L, etal., Am J Respir Crit Care Med. 2009 Jun 15;179(12):1141-50. doi: 10.1164/rccm.200806-908OC. Epub 2009 Jan 16.
36. Inhibition of non-neuronal alpha7-nicotinic receptor reduces tumorigenicity in A549 NSCLC xenografts. Paleari L, etal., Int J Cancer. 2009 Jul 1;125(1):199-211. doi: 10.1002/ijc.24299.
37. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
38. An alpha7 nicotinic acetylcholine receptor gain-of-function mutant that retains pharmacological fidelity. Placzek AN, etal., Mol Pharmacol. 2005 Dec;68(6):1863-76. Epub 2005 Sep 26.
39. GOA pipeline RGD automated data pipeline
40. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
41. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
42. Involvement of alpha 7 nicotinic acetylcholine receptors in gene expression of dopamine biosynthetic enzymes in rat brain. Serova L and Sabban EL, J Pharmacol Exp Ther 2002 Dec;303(3):896-903.
43. Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. Shaw S, etal., J Biol Chem 2002 Nov 22;277(47):44920-4.
44. Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3'] oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand. Tatsumi R, etal., J Med Chem. 2005 Apr 7;48(7):2678-86.
45. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology. Teaktong T, etal., J Neurol Sci 2004 Oct 15;225(1-2):39-49.
46. Lynx1 and Aβ1-42 bind competitively to multiple nicotinic acetylcholine receptor subtypes. Thomsen MS, etal., Neurobiol Aging. 2016 Oct;46:13-21. doi: 10.1016/j.neurobiolaging.2016.06.009. Epub 2016 Jun 17.
47. Functional properties of internalization-deficient P2X4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin. Toulme E, etal., Mol Pharmacol. 2006 Feb;69(2):576-87. Epub 2005 Nov 10.
48. Role of the large cytoplasmic loop of the alpha 7 neuronal nicotinic acetylcholine receptor subunit in receptor expression and function. Valor LM, etal., Biochemistry 2002 Jun 25;41(25):7931-8.
49. Nicotinic acetylcholine receptor subtypes in rat superior cervical ganglion neurons as studied by sequential application of two alpha-subunit-specific antibodies. Voitenko LP, etal., Neurosci Lett. 2001 Apr 27;303(1):37-40.
50. Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer's disease pathogenesis. Wang HY, etal., Alzheimers Res Ther. 2017 Jul 27;9(1):54. doi: 10.1186/s13195-017-0280-8.
51. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. Wang HY, etal., J Biol Chem. 2000 Feb 25;275(8):5626-32.
52. Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling. Wang L, etal., Oncogene. 2021 Mar;40(11):1974-1987. doi: 10.1038/s41388-021-01682-z. Epub 2021 Feb 18.
53. Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-κB/HMGB1/RAGE and p-AKT/Bcl-2 pathways. Wazea SA, etal., Sci Rep. 2018 Mar 23;8(1):5110. doi: 10.1038/s41598-018-23359-6.
54. Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer. Yang L, etal., Eur J Hum Genet. 2015 Aug;23(8):1019-24. doi: 10.1038/ejhg.2014.229. Epub 2014 Nov 19.
55. Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Young JW, etal., Neuropsychopharmacology. 2004 May;29(5):891-900. doi: 10.1038/sj.npp.1300393.
56. Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus. Zappettini S, etal., Neurochem Int. 2011 Oct;59(5):729-38. doi: 10.1016/j.neuint.2011.06.022. Epub 2011 Jul 5.
Additional References at PubMed
PMID:1400473   PMID:7678857   PMID:8145738   PMID:8906617   PMID:9037516   PMID:9364063   PMID:9495872   PMID:10771023   PMID:10800961   PMID:10942027   PMID:11278551   PMID:11834293  
PMID:12059039   PMID:12079404   PMID:12189247   PMID:12411519   PMID:12508119   PMID:12605456   PMID:12898272   PMID:15296793   PMID:15322233   PMID:15364017   PMID:15469877   PMID:15489024  
PMID:15504725   PMID:15541879   PMID:15555774   PMID:15601930   PMID:15622441   PMID:15635599   PMID:15705531   PMID:15885267   PMID:15922075   PMID:15944242   PMID:15955596   PMID:15963492  
PMID:16025111   PMID:16025117   PMID:16033766   PMID:16141265   PMID:16144967   PMID:16253349   PMID:16269536   PMID:16280133   PMID:16403644   PMID:16652343   PMID:16690715   PMID:16754836  
PMID:16772172   PMID:16772524   PMID:16785311   PMID:16837558   PMID:16923147   PMID:16931547   PMID:16959216   PMID:17068140   PMID:17192608   PMID:17192655   PMID:17291692   PMID:17470777  
PMID:17498763   PMID:17510177   PMID:17545063   PMID:17548533   PMID:17950703   PMID:18096596   PMID:18164502   PMID:18174677   PMID:18215234   PMID:18222041   PMID:18256594   PMID:18297099  
PMID:18310132   PMID:18387948   PMID:18458158   PMID:18512214   PMID:18614620   PMID:19007816   PMID:19057014   PMID:19063868   PMID:19118188   PMID:19187266   PMID:19230830   PMID:19246390  
PMID:19368825   PMID:19372354   PMID:19374941   PMID:19424097   PMID:19586999   PMID:19587288   PMID:19602049   PMID:19619852   PMID:19637277   PMID:19682509   PMID:19688191   PMID:19762524  
PMID:20004706   PMID:20051354   PMID:20153739   PMID:20164328   PMID:20211606   PMID:20309583   PMID:20347906   PMID:20598018   PMID:20599427   PMID:20633015   PMID:20634896   PMID:20708605  
PMID:20817852   PMID:20837638   PMID:20857232   PMID:20943921   PMID:20974225   PMID:21099147   PMID:21103043   PMID:21339364   PMID:21343288   PMID:21346795   PMID:21665194   PMID:21718690  
PMID:21857926   PMID:21858872   PMID:22127290   PMID:22253754   PMID:22351110   PMID:22479351   PMID:22649244   PMID:22682236   PMID:22778816   PMID:22848433   PMID:22956546   PMID:22962286  
PMID:23091164   PMID:23157401   PMID:23184186   PMID:23201359   PMID:23219030   PMID:23270857   PMID:23749479   PMID:23842742   PMID:24032433   PMID:24177919   PMID:24340009   PMID:24360204  
PMID:24486841   PMID:24525957   PMID:24687992   PMID:25231613   PMID:25447771   PMID:25553616   PMID:25798813   PMID:25810076   PMID:25966616   PMID:26498641   PMID:26522221   PMID:26806304  
PMID:27106269   PMID:27129924   PMID:27339462   PMID:28039041   PMID:28834708   PMID:28842280   PMID:29117064   PMID:29307658   PMID:29665360   PMID:29672286   PMID:29679680   PMID:29768467  
PMID:30249754   PMID:30345917   PMID:30452951   PMID:30947238   PMID:31062470   PMID:31176021   PMID:31398352   PMID:31541709   PMID:33092257   PMID:33352289   PMID:33514001   PMID:33636639  
PMID:33691518   PMID:34052301   PMID:34061415   PMID:34225758   PMID:34920740   PMID:34946750   PMID:35141983   PMID:36167538   PMID:36375307   PMID:36912917  


Genomics

Comparative Map Data
Chrna7
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.21116,711,559 - 116,837,269 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1116,714,711 - 116,837,240 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1124,676,761 - 124,793,917 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01131,859,276 - 131,976,435 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01124,684,982 - 124,802,138 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01123,897,341 - 124,039,263 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1123,899,657 - 124,039,196 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01125,029,451 - 125,158,153 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41117,587,580 - 117,716,267 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11117,665,347 - 117,794,621 (-)NCBI
Celera1108,976,664 - 109,097,764 (-)NCBICelera
Cytogenetic Map1q22NCBI
CHRNA7
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381532,030,483 - 32,173,018 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1531,923,438 - 32,173,018 (+)EnsemblGRCh38hg38GRCh38
GRCh371532,322,686 - 32,465,219 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361530,110,018 - 30,248,541 (+)NCBINCBI36Build 36hg18NCBI36
Build 341530,110,017 - 30,248,525NCBI
Celera158,162,865 - 8,292,202 (-)NCBICelera
Cytogenetic Map15q13.3NCBI
HuRef159,499,328 - 9,603,273 (+)NCBIHuRef
CHM1_11532,312,897 - 32,452,812 (+)NCBICHM1_1
T2T-CHM13v2.01529,824,630 - 29,967,342 (+)NCBIT2T-CHM13v2.0
Chrna7
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39762,748,440 - 62,862,274 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl762,748,440 - 62,862,317 (-)EnsemblGRCm39 Ensembl
GRCm38763,098,692 - 63,212,526 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl763,098,692 - 63,212,569 (-)EnsemblGRCm38mm10GRCm38
MGSCv37770,243,578 - 70,357,412 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36762,977,642 - 63,091,468 (-)NCBIMGSCv36mm8
Celera760,542,827 - 60,660,378 (-)NCBICelera
Cytogenetic Map7CNCBI
cM Map734.47NCBI
Chrna7
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495541630,687,478 - 30,798,700 (+)EnsemblChiLan1.0
ChiLan1.0NW_00495541630,687,518 - 30,798,700 (+)NCBIChiLan1.0ChiLan1.0
CHRNA7
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan11525,565,746 - 25,705,121 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01510,525,535 - 10,667,227 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11529,565,885 - 29,705,194 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1529,565,885 - 29,705,194 (+)Ensemblpanpan1.1panPan2
CHRNA7
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1336,852,082 - 37,164,930 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl336,852,543 - 36,978,399 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha339,517,659 - 39,644,156 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0337,232,973 - 37,359,572 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl337,231,040 - 37,360,220 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1336,756,424 - 36,882,829 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0337,011,929 - 37,138,401 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0337,222,873 - 37,349,426 (-)NCBIUU_Cfam_GSD_1.0
Chrna7
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_024408640146,502,956 - 146,512,072 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_00493735134,921 - 47,246 (-)EnsemblSpeTri2.0
SpeTri2.0NW_00493735132,324 - 46,871 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
CHRNA7
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1142,803,701 - 142,937,123 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11142,803,697 - 142,937,124 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21158,717,002 - 158,849,994 (-)NCBISscrofa10.2Sscrofa10.2susScr3
CHRNA7
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.12650,554,143 - 50,686,847 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl2650,551,829 - 50,686,803 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366604890,139,706 - 90,283,400 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Chrna7
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_004624768909,099 - 1,024,902 (-)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_004624768908,907 - 1,024,953 (-)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in Chrna7
604 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:56
Count of miRNA genes:53
Interacting mature miRNAs:53
Transcripts:ENSRNOT00000051883
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1358359Sradr1Stress Responsive Adrenal Weight QTL 14.74adrenal gland mass (VT:0010420)both adrenal glands wet weight (CMO:0000164)130882023123479925Rat
70225Bp58Blood pressure QTL 583.3arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)132356093162846471Rat
10059597Bp377Blood pressure QTL 3773.420.025arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)132737458199368955Rat
2313051Bss57Bone structure and strength QTL 573.70.0001tibia strength trait (VT:1000284)bone polar moment of inertia (CMO:0001558)143284731118944897Rat
2313059Bss55Bone structure and strength QTL 553.20.0001tibia size trait (VT:0100001)tibia midshaft cross-sectional area (CMO:0001717)143284731118944897Rat
2313072Bss53Bone structure and strength QTL 534.30.0001tibia length (VT:0004357)tibia length (CMO:0000450)143284731118944897Rat
2313078Bss54Bone structure and strength QTL 543.50.0001tibia area (VT:1000281)tibia midshaft cross-sectional area (CMO:0001717)143284731118944897Rat
2313094Bss58Bone structure and strength QTL 583.70.0001tibia strength trait (VT:1000284)tibia total energy absorbed before break (CMO:0001736)143284731118944897Rat
2313098Bmd70Bone mineral density QTL 703.60.0001tibia mineral mass (VT:1000283)compact volumetric bone mineral density (CMO:0001730)143284731118944897Rat
2313099Bss56Bone structure and strength QTL 562.40.0001tibia size trait (VT:0100001)tibia midshaft endosteal cross-sectional area (CMO:0001716)143284731118944897Rat
2313402Anxrr24Anxiety related response QTL 24aggression-related behavior trait (VT:0015014)tameness/aggressiveness composite score (CMO:0002136)148963584144267916Rat
1578654Bss10Bone structure and strength QTL 104femur morphology trait (VT:0000559)femoral neck cortical cross-sectional area (CMO:0001702)149393172159356837Rat
634314Niddm44Non-insulin dependent diabetes mellitus QTL 44blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)149393289199050459Rat
2298545Neuinf8Neuroinflammation QTL 84.6nervous system integrity trait (VT:0010566)spinal cord beta-2 microglobulin mRNA level (CMO:0002125)157336763151090257Rat
7421628Bp361Blood pressure QTL 3610.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)166023617118608521Rat
1358192Ept13Estrogen-induced pituitary tumorigenesis QTL 133.4pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)177494165122494165Rat
10054135Gmadr2Adrenal mass QTL 21.970.0129adrenal gland mass (VT:0010420)both adrenal glands wet weight (CMO:0000164)177857876122857876Rat
61344Bp29Blood pressure QTL 297.5arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)178350581123350581Rat
7411712Strs4Sensitivity to stroke QTL 48.7cerebrum integrity trait (VT:0010549)percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932)178430536123430536Rat
1582234Gluco18Glucose level QTL 183.40.0003blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)178479925123479925Rat
4889494Scort2Serum corticosterone level QTL 24.2blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)180592172125592172Rat
1578780Cm52Cardiac mass QTL 523.30.0001heart mass (VT:0007028)heart wet weight (CMO:0000069)181591954219808434Rat
2313083Bmd74Bone mineral density QTL 7440.0001tibia mineral mass (VT:1000283)total volumetric bone mineral density (CMO:0001728)182174743118944897Rat
738022Anxrr13Anxiety related response QTL 134.60.00039locomotor behavior trait (VT:0001392)number of 20 x 20 cm floor squares crossed into, out of or within a discrete space in an experimental apparatus (CMO:0001514)183547917128547917Rat
724529Cm16Cardiac mass QTL 162.7heart mass (VT:0007028)calculated heart weight (CMO:0000073)187580395150700247Rat
724521Uae1Urinary albumin excretion QTL 13.80.0001urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)190508614173018436Rat
1358902Bw47Body weight QTL 471.67body mass (VT:0001259)body weight (CMO:0000012)190508614180359386Rat
1302788Scl19Serum cholesterol QTL 194.60.001blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)190532338123479925Rat
1300153Bp171Blood pressure QTL 1713.37arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)190664883143200202Rat
2293142Bp314Blood pressure QTL 314arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)192184926137184926Rat
724567Tcas6Tongue tumor susceptibility QTL 66.85tongue integrity trait (VT:0010553)number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950)192948896144267916Rat
1331800Scl25Serum cholesterol level QTL 253.013blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)194494440117601394Rat
1331793Bp200Blood pressure QTL 2003.71601arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)194494440172949803Rat
1331751Bp199Blood pressure QTL 1993.60022arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)194494440181830018Rat
1331749Hrtrt11Heart rate QTL 112.973heart pumping trait (VT:2000009)heart rate (CMO:0000002)194494440198211706Rat
70209Niddm23Non-insulin dependent diabetes mellitus QTL 232.82blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)194494440198324465Rat
731168Bp154Blood pressure QTL 1543.4arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)194642644214537671Rat
61346Rf2Renal disease susceptibility QTL 23.7urine protein amount (VT:0005160)urine protein level (CMO:0000591)199267916144267916Rat
61399Tcat1Tongue tumor resistance QTL 13.3tongue integrity trait (VT:0010553)number of squamous cell tumors of the tongue with diameter greater than 5 mm (CMO:0001879)199267916144267916Rat
8655649Arrd1Age-related retinal degeneration QTL 14.89retinal layer morphology trait (VT:0003727)percentage of study population developing retinopathy during a period of time (CMO:0002453)1100357752183970443Rat
2317833Alcrsp19Alcohol response QTL 1912.40.001response to alcohol trait (VT:0010489)duration of loss of righting reflex (CMO:0002289)1100979852145979852Rat
1641897Alcrsp1Alcohol response QTL 1response to alcohol trait (VT:0010489)duration of loss of righting reflex (CMO:0002289)1100979852145979852Rat
2303591Gluco41Glucose level QTL 412blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1102168504147168504Rat
61370Mcs3Mammary carcinoma susceptibility QTL 32.15mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)1102268556147268556Rat
1354623Rf46Renal function QTL 463.8blood creatinine amount (VT:0005328)plasma creatinine level (CMO:0000537)1102813953151162766Rat
1354591Cm36Cardiac mass QTL 364.1heart left ventricle mass (VT:0007031)calculated heart weight (CMO:0000073)1102813953201278233Rat
1354615Cm32Cardiac mass QTL 325.2heart left ventricle mass (VT:0007031)heart left ventricle wet weight (CMO:0000071)1102813953201278233Rat
1354606Bp246Blood pressure QTL 2463.6arterial blood pressure trait (VT:2000000)pulse pressure (CMO:0000292)1102813953218753816Rat
9590300Scort16Serum corticosterone level QTL 164.390.001blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)1103111621148111621Rat
8694370Bw154Body weight QTL 1548.910.001body lean mass (VT:0010483)lean tissue morphological measurement (CMO:0002184)1103111621148111621Rat
631569Bp93Blood pressure QTL 930.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1106047847121834139Rat
631496Bp97Blood pressure QTL 973.08arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1106047847151047847Rat
1300158Bp173Blood pressure QTL 1733.48arterial blood pressure trait (VT:2000000)blood pressure time series experimental set point of the baroreceptor response (CMO:0002593)1115540693185145286Rat
7794788Mcs32Mammary carcinoma susceptibility QTL 322.61mammary gland integrity trait (VT:0010552)mammary tumor incidence/prevalence measurement (CMO:0000946)1115540693238914717Rat
631199Cm23Cardiac mass QTL 234.60.0004heart left ventricle mass (VT:0007031)heart left ventricle wet weight (CMO:0000071)1115585465172949803Rat

Markers in Region
D1Got316  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21116,831,353 - 116,831,565 (+)MAPPERmRatBN7.2
Rnor_6.01124,033,325 - 124,033,536NCBIRnor6.0
Rnor_5.01125,152,285 - 125,152,496UniSTSRnor5.0
RGSC_v3.41117,710,426 - 117,710,637UniSTSRGSC3.4
Celera1109,091,897 - 109,092,108UniSTS
Cytogenetic Map1q22UniSTS
D1Bda22  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21116,714,895 - 116,715,248 (+)MAPPERmRatBN7.2
Rnor_6.01123,900,674 - 123,901,026NCBIRnor6.0
Rnor_5.01125,029,061 - 125,029,413UniSTSRnor5.0
RGSC_v3.41117,587,190 - 117,587,542UniSTSRGSC3.4
Celera1108,976,274 - 108,976,626UniSTS
Cytogenetic Map1q22UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
High
Medium 8 43 7 7
Low 3 20 26 18 19 18 8 9 31 27 34 4 8
Below cutoff 13 15 15 15 2 4

Sequence


Reference Sequences
RefSeq Acc Id: ENSRNOT00000051883   ⟹   ENSRNOP00000045255
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1116,715,283 - 116,837,226 (-)Ensembl
Rnor_6.0 Ensembl1123,901,061 - 124,039,196 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000082487   ⟹   ENSRNOP00000073551
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1116,714,711 - 116,837,240 (-)Ensembl
Rnor_6.0 Ensembl1123,899,657 - 124,038,966 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000100474   ⟹   ENSRNOP00000082768
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1116,714,711 - 116,786,132 (-)Ensembl
RefSeq Acc Id: NM_012832   ⟹   NP_036964
RefSeq Status: VALIDATED
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21116,711,559 - 116,837,269 (-)NCBI
Rnor_6.01123,901,064 - 124,039,193 (-)NCBI
Rnor_5.01125,029,451 - 125,158,153 (-)NCBI
RGSC_v3.41117,587,580 - 117,716,267 (-)RGD
Celera1108,976,664 - 109,097,764 (-)RGD
Sequence:
Reference Protein Sequences
RefSeq Acc Id: NP_036964   ⟸   NM_012832
- Peptide Label: precursor
- UniProtKB: Q53YK2 (UniProtKB/Swiss-Prot),   Q05941 (UniProtKB/Swiss-Prot),   A6JBJ4 (UniProtKB/TrEMBL),   Q5UMH9 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000073551   ⟸   ENSRNOT00000082487
RefSeq Acc Id: ENSRNOP00000045255   ⟸   ENSRNOT00000051883
RefSeq Acc Id: ENSRNOP00000082768   ⟸   ENSRNOT00000100474
Protein Domains
Neurotransmitter-gated ion-channel ligand-binding   Neurotransmitter-gated ion-channel transmembrane

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q05941-F1-model_v2 AlphaFold Q05941 1-502 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen


Additional Information

Database Acc Id Source(s)
AGR Gene RGD:2348 AgrOrtholog
BioCyc Gene G2FUF-59106 BioCyc
Ensembl Genes ENSRNOG00000010853 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000051883.5 UniProtKB/TrEMBL
  ENSRNOT00000082487 ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ENSRNOT00000100474.1 UniProtKB/TrEMBL
Gene3D-CATH 1.20.58.390 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  2.70.170.10 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
InterPro Neur_chan_lig-bd UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Neur_chan_lig-bd_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Neur_channel UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Neuro-gated_channel_TM_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Neuro_actylchol_rec UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Neurotrans-gated_channel_TM UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Neurotransmitter_ion_chnl_CS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Nicotinic_acetylcholine_rcpt UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:25302 UniProtKB/Swiss-Prot
NCBI Gene 25302 ENTREZGENE
PANTHER NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-7 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  PTHR18945 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam Neur_chan_LBD UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Neur_chan_memb UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB CHRNA7 RGD
PhenoGen Chrna7 PhenoGen
PRINTS NICOTINICR UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  NRIONCHANNEL UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PROSITE NEUROTR_ION_CHANNEL UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
RatGTEx ENSRNOG00000010853 RatGTEx
Superfamily-SCOP SSF63712 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  SSF90112 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt A0A0G2K5T5_RAT UniProtKB/TrEMBL
  A0A8I5ZXW5_RAT UniProtKB/TrEMBL
  A6JBJ4 ENTREZGENE, UniProtKB/TrEMBL
  A6JBJ5_RAT UniProtKB/TrEMBL
  A6JBJ6_RAT UniProtKB/TrEMBL
  A6JBJ7_RAT UniProtKB/TrEMBL
  ACHA7_RAT UniProtKB/Swiss-Prot, ENTREZGENE
  Q53YK2 ENTREZGENE
  Q5UMH9 ENTREZGENE, UniProtKB/TrEMBL
UniProt Secondary Q53YK2 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-02-11 Chrna7  cholinergic receptor nicotinic alpha 7 subunit  Chrna7  cholinergic receptor, nicotinic, alpha 7  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2015-11-12 Chrna7  cholinergic receptor, nicotinic, alpha 7  Chrna7  cholinergic receptor, nicotinic, alpha 7 (neuronal)  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2012-07-16 Chrna7  cholinergic receptor, nicotinic, alpha 7 (neuronal)  Chrna7  cholinergic receptor, nicotinic, alpha 7  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2008-09-29 Chrna7  cholinergic receptor, nicotinic, alpha 7  Chrna7  cholinergic receptor, nicotinic, alpha polypeptide 7   Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2002-11-06 Chrna7  cholinergic receptor, nicotinic, alpha polypeptide 7     C holinergic receptor, nicotinic, alpha polypeptide 7 (neuronal nicotinic acetycholine receptor alpha 7) (bungarotoxin alpha)  Name updated 625702 APPROVED
2002-06-10 Chrna7  C holinergic receptor, nicotinic, alpha polypeptide 7 (neuronal nicotinic acetycholine receptor alpha 7) (bungarotoxin alpha)      Symbol and Name status set to approved 70586 APPROVED

RGD Curation Notes
Note Type Note Reference
gene_pathway activates phosphatidylinositol 3-kinase via Janus kinase 2 (JAK2) activation pathway 633056